PE Owners Mull $1.2B Sale Of Medpace Clinical Research Unit
The private equity firm behind Medpace Inc. is preparing to exit the clinical research company in a deal expected to bring in up to $1.2 billion, a source familiar with the...To view the full article, register now.
Already a subscriber? Click here to view full article